Gabra1 Conditional Knockout mouse models

Gabra1 encodes the α1 subunit of the GABA-A receptor, ortholog of human GABRA1, and is the most abundant α isoform in brain, assembling predominantly as α1β2γ2 pentamers at synapses where the benzodiazepine site is formed at the α1 and γ2 interface and requires His101 for high-affinity diazepam binding. Dominant human variants including A322D and pore-lining substitutions cause juvenile myoclonic epilepsy and developmental and epileptic encephalopathy through dominant negative assembly failure and reduced surface receptor rather than simple haploinsufficiency. The classic knockin H101R, which renders α1 diazepam-insensitive, remains the definitive demonstration that this subunit mediates the sedative and amnestic components of benzodiazepine action, and it exemplifies the point-mutation strategy for dissecting pharmacology. Constitutive nulls are viable with tremor and near-total loss of brain benzodiazepine binding, so choose a conditional null for circuit assignment, a patient knockin for encephalopathy modeling, and pair either with EEG and interneuron-specific Cre drivers.

Conditional deletion of Gabra1 limits the genetic change to the lineage you choose. That helps in oncology, immunology, and metabolic work where systemic loss would muddy the read. After you confirm Cre specificity, crossing to Gabra1 floxed stock yields usable cohorts.